Cypris Therapeutics

Cypris Therapeutics is a drug discovery company launched after achieving a breakthrough in synthetic chemistry technology, which enables the development of novel chemical substances for treating drug-resistant diseases, including brain cancer and pancreatic cancer. The company’s proprietary technology allows for the synthesis and iteration of complex small molecule components that researchers were previously unable to achieve.